These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 8254389

  • 21. [Usefulness of 18F-fluorodeoxyglucose positron emission tomography for evaluating myocardial viability in old myocardial infarction].
    Niwayama H, Yoshida K, Masuda Y, Inagaki Y.
    Kaku Igaku; 1992 Nov; 29(11):1341-52. PubMed ID: 1484426
    [Abstract] [Full Text] [Related]

  • 22. [Ischemic myocardial injury evaluated using positron emission tomography in children with coronary artery disease: comparison with thallium-201 SPECT].
    Yoshibayashi M, Tamaki N, Nishioka K, Matsumura M, Yonekura Y, Yamashita K, Konishi J, Ban T, Mikawa H.
    J Cardiol; 1992 Nov; 22(1):21-6. PubMed ID: 1307567
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.
    Herrero P, Sharp TL, Dence C, Haraden BM, Gropler RJ.
    J Nucl Med; 2002 Nov; 43(11):1530-41. PubMed ID: 12411556
    [Abstract] [Full Text] [Related]

  • 25. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
    Mariani MA, Palagi C, Donatelli F, Mengozzi G, Biadi O, Vanoli G, Landoni C, Paolini G, Lucignani G, Fazio F.
    Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227
    [Abstract] [Full Text] [Related]

  • 26. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
    Morita K, Katoh C, Yoshinaga K, Noriyasu K, Mabuchi M, Tsukamoto T, Kageyama H, Shiga T, Kuge Y, Tamaki N.
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
    [Abstract] [Full Text] [Related]

  • 27. Relation between myocardial 18F-FDG uptake in the fasting state and coronary angiography in patients with coronary artery disease.
    Huang G, Lucignani G, Landoni C, Galli L, Paganelli G, Rossetti C, Del Sole A, Fazio F.
    Nucl Med Commun; 1994 May; 15(5):311-6. PubMed ID: 8047316
    [Abstract] [Full Text] [Related]

  • 28. [Comparison of relative 18FDG uptake with metabolic rate (MRGlucose) in the myocardium in CAD, classified by 99m-Tc-MIBI].
    Büll U, Foroutan Y, Hellwig D, Kaiser HJ, Schulz G, Sabri O, Schreckenberger M, vom Dahl J.
    Nuklearmedizin; 1995 Dec; 34(6):223-8. PubMed ID: 8596738
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping.
    Bax JJ, Visser FC, Raymakers PG, Van Lingen A, Cornel JH, Huitink JM, Elhendy A, Heine RJ, Visser CA.
    Nucl Med Commun; 1997 Mar; 18(3):200-6. PubMed ID: 9106773
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET.
    Tamaki N, Ohtani H, Yonekura Y, Shindo M, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J.
    J Cardiol; 1992 Mar; 22(2-3):283-93. PubMed ID: 1339787
    [Abstract] [Full Text] [Related]

  • 35. Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: evaluation of tracer kinetics in a type 1 diabetes model.
    Thorn SL, deKemp RA, Dumouchel T, Klein R, Renaud JM, Wells RG, Gollob MH, Beanlands RS, DaSilva JN.
    J Nucl Med; 2013 Sep; 54(9):1637-44. PubMed ID: 23940301
    [Abstract] [Full Text] [Related]

  • 36. Role of positron emission tomography using fluorine-18 fluoro-2-deoxyglucose in predicting improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy.
    Yokoyama I, Momomura S, Ohtake T, Yonekura K, Inoue Y, Kobayakawa N, Aoyagi T, Sugiura S, Nishikawa J, Sasaki Y, Omata M.
    Eur J Nucl Med; 1998 Jul; 25(7):736-43. PubMed ID: 9662596
    [Abstract] [Full Text] [Related]

  • 37. [The recent studies of myocardial blood flow and metabolism by using positron emission computed tomography].
    Ohtake T, Yokoyama I, Serizawa T, Nishikawa J, Sasaki Y.
    Kaku Igaku; 1993 Mar; 30(3):331-9. PubMed ID: 8479102
    [Abstract] [Full Text] [Related]

  • 38. [Glucose metabolism in ischemic myocardium: quantitative imaging using positron emission tomography].
    Takahashi A, Ono Y, Sudo M, Araki K, Shishido F, Uemura K, Kadowaki K, Kumagai T.
    J Cardiogr; 1986 Jun; 16(2):291-9. PubMed ID: 3495606
    [Abstract] [Full Text] [Related]

  • 39. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G, Schneider-Eicke J, Schwaiger M.
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.